Apoptosis repressor with caspase recruitment domain (ARC) (ARC)

Apoptosis repressor with caspase recruitment domain (ARC), encoded by the NOL3 gene, is a potent, multifunctional inhibitor of programmed cell death that is uniquely capable of suppressing both intrinsic and extrinsic apoptotic pathways [UniProt P50479, PubMed 15661555]. It functions by physically interacting with and sequestering key pro-apoptotic proteins, including Caspase-8, Caspase-2, and BAX, thereby preventing their activation and the subsequent execution of the cell death program [PubMed 11048727, PubMed 12193631]. While ARC is physiologically expressed primarily in terminally differentiated tissues such as the heart and skeletal muscle where it serves a critical cardioprotective role, its pathological overexpression is observed in a wide array of human malignancies [PubMed 15661555, PubMed 16131494]. In cancer, ARC overexpression promotes tumor cell survival, facilitates resistance to chemotherapeutic agents and radiation, and supports metastatic potential [PubMed 21536911]. Because of its role in treatment resistance, ARC is considered a significant therapeutic target in oncology; however, its essential function in maintaining cardiac integrity presents a major safety challenge, as systemic inhibition could lead to severe cardiotoxicity [PubMed 16754801].

Other names

Nucleolar protein 3NOL3Apoptosis repressor with CARDMuscle-specific protein 30 kDaMYPNOPNOP30

ARC acts as a dominant-negative inhibitor by using its N-terminal CARD domain to bind the CARD domains of Caspase-2 and Caspase-8, and its C-terminal domain to bind BAX, effectively blocking both death receptor-mediated and mitochondrial-mediated apoptosis [UniProt P50479, PubMed 11048727].